Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway.
Klotho was first identified in 1997 and has been considered as an anti-aging gene. Emerging evidence demonstrates that klotho has a close relationship with cancers, including lung cancer, breast cancer, etc, by inhibiting the proliferation and promoting apoptosis of cancer cells. Cisplatin has been...
Main Authors: | Yan Wang, Lei Chen, Guochang Huang, Dongmei He, Juan He, Wei Xu, Chunying Zou, Feng Zong, Yan Li, Bo Chen, Shuanshuan Wu, Weihong Zhao, Jianqing Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3578855?pdf=render |
Similar Items
-
RETRACTED: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
by: Li-Mei Wu, et al.
Published: (2021-02-01) -
Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549
by: Zhao Weihong, et al.
Published: (2010-07-01) -
Inhibition of histone methyltransferase PRMT5 attenuates cisplatin-induced hearing loss through the PI3K/Akt-mediated mitochondrial apoptotic pathway
by: Zhiwei Zheng, et al.
Published: (2023-06-01) -
UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis
by: Xiwen Wu, et al.
Published: (2024-08-01) -
Effect of PI3K/AKT Pathway on Cisplatin Resistance in Non-small Cell Lung Cancer
by: Yu ZHANG, et al.
Published: (2014-08-01)